Grade III glioma
MONDO:0021640A group of malignant gliomas that includes anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic oligoastrocytoma, and anaplastic ependymoma.
Also known as: WHO grade III glioma, anaplastic glioma
2893 clinical trials for this condition and its sub-types, 44 tagged with Grade III glioma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Grade III glioma
-
Anaplastic oligodendroglioma 22 trials · 37 incl. sub-types
1 sub-type
- IDH-mutant and 1p/19q-codeleted oligodendroglioma 10 trials · 15 incl. sub-types Sub-types →
-
Anaplastic oligoastrocytoma 12 trials
-
Anaplastic ependymoma 7 trials · 12 incl. sub-types
3 sub-types
- Posterior fossa ependymoma 3 trials Sub-types →
- Adult anaplastic ependymoma 1 trial
- Supratentorial ependymoma 1 trial Sub-types →
Most studied deeper sub-types
-
Promising drug combo targets aggressive brain cancers in youth
Disease control Not yet recruitingThis study is for adolescents and young adults (ages 12-39) newly diagnosed with aggressive brain tumors called high-grade glioma or DIPG. The goal is to see if a combination of two immunotherapy drugs (relatlimab and nivolumab, sold as Opdualag) is safe and tolerable when given …
Phase 2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for kids with deadly brain cancer: targeted drug trial launches
Disease control Not yet recruitingThis study tests a drug called tovorafenib in children and young adults (ages 1 to 39) newly diagnosed with aggressive brain tumors (high-grade glioma or DIPG) that have specific genetic changes. The goal is to see if the drug can help them live longer. About 79 participants will…
Phase 2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC